STOK compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

STOKStoke Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

STOKStoke Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

STOKStoke Therapeutics, Inc.

26.99· pre 26.85· delayed

Mkt cap$1.8BRevenue$11MQ3 FY26Revenue$184MFY25

LLYELI Lilly & Co

1,407.25· pre 1,422.00· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 4 '26delayed

STOKStoke Therapeutics, Inc.

LLYELI Lilly & Co

26.99pre 26.85delayed

Price

1,407.25pre 1,422.00delayed

$1.8B

Mkt cap

$1.3T

Q3 FY26$11M

Revenue

$24.4BQ3 FY26

FY25$184M

Revenue

$65.2BFY25

STOK26.99vsLLY1,407.25Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

STOK: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STOK 3

BIIBBiogen International GmbHcustomer

ACADAcadia Pharmaceuticalscustomer

—NWALP PHOP Property Ownerunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

STOK, solidLLY, dashed